Umbilical cord tissue-derived mesenchymal stem cells grow best under GMP-compliant culture conditions and maintain their phenotypic and functional properties

被引:58
作者
Hartmann, Isabel [1 ]
Hollweck, Trixi [1 ]
Haffner, Silvia [1 ]
Krebs, Michaela [1 ]
Meiser, Bruno [1 ]
Reichart, Bruno [1 ]
Eissner, Guenther [1 ]
机构
[1] Univ Munich, Dept Cardiac Surg, D-81377 Munich, Germany
关键词
Differentiation; Mixed lymphocyte reaction; Prostaglandin E-2; Transwell system; Serum-free; Xeno-free; TRANSPLANTATION; THERAPY; MSC;
D O I
10.1016/j.jim.2010.10.008
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Mesenchymal stem cells (MSCs) are fibroblast-like multipotent stem cells that can differentiate into cell types of mesenchymal origin. Because of their immune properties and differentiation, potential MSCs are discussed for the use in tissue regeneration and tolerance induction in transplant medicine. This cell type can easily be obtained from the umbilical cord tissue (UCMSC) without medical intervention. Standard culture conditions include fetal bovine serum (FBS) which may not be approved for clinical settings. Here, we analyzed the phenotypic and functional properties of UCMSC under xeno-free (XF, containing GMP-certified human serum) and serum-free (SF) culture conditions in comparison with standard UCMSC cultures. Phenotypically, UCMSC showed no differences in the expression of mesenchymal markers or differentiation capacity. Functionally, XF and SF-cultured UCMSC have comparable adipogenic, osteogenic, and endothelial differentiation potential. Interestingly, the UCMSC-mediated suppression of T cell proliferation in an allogeneic mixed lymphocyte reaction (MLR) is more effective in XF and SF media than in standard FBS-containing cultures. Regarding the mechanism of action of MLR suppression, transwell experiments revealed that in neither UCMSC culture a direct cell-cell contact is necessary for inhibiting T cell proliferation, and that the major effector molecule is prostaglandin E-2 (PGE(2)). Taken together, GMP-compliant growth media qualify for long-term cultures of UCMSC which is important for a future clinical study design in regenerative and transplant medicine. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:80 / 89
页数:10
相关论文
共 33 条
[1]   Human mesenchymal stem cells modulate allogeneic immune cell responses [J].
Aggarwal, S ;
Pittenger, MF .
BLOOD, 2005, 105 (04) :1815-1822
[2]  
Angulo R, 1998, CYTOMETRY, V34, P143, DOI 10.1002/(SICI)1097-0320(19980615)34:3<143::AID-CYTO4>3.0.CO
[3]  
2-I
[4]   Potential risks of bone marrow cell transplantation into infarcted hearts [J].
Breitbach, Martin ;
Bostani, Toktam ;
Roell, Wilhelm ;
Xia, Ying ;
Dewald, Oliver ;
Nygren, Jens M. ;
Fries, Jochen W. U. ;
Tiemann, Klaus ;
Bohlen, Heribert ;
Hescheler, Juergen ;
Welz, Armin ;
Bloch, Wilhelm ;
Jacobsen, Sten Eirik W. ;
Fleischmann, Bernd K. .
BLOOD, 2007, 110 (04) :1362-1369
[5]   Native umbilical cord matrix stem cells express hepatic markers and differentiate into hepatocyte-like cells [J].
Campard, David ;
Lysy, Philippe A. ;
Najimi, Mustapha ;
Sokal, E-Fienne Marc .
GASTROENTEROLOGY, 2008, 134 (03) :833-848
[6]   Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells [J].
Chen, Ming-Yan ;
Lie, Pu-Chang ;
Li, Zhi-Ling ;
Wei, Xing .
EXPERIMENTAL HEMATOLOGY, 2009, 37 (05) :629-640
[7]   Isolation and culture of umbilical vein mesenchymal stem cells [J].
Covas, DT ;
Siufi, JLC ;
Silva, ARL ;
Orellana, MD .
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2003, 36 (09) :1179-1183
[8]   Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli [J].
Di Nicola, M ;
Carlo-Stella, C ;
Magni, M ;
Milanesi, M ;
Longoni, PD ;
Matteucci, P ;
Grisanti, S ;
Gianni, AM .
BLOOD, 2002, 99 (10) :3838-3843
[9]   Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells [J].
Groh, ME ;
Maitra, B ;
Szekely, E ;
Koç, ON .
EXPERIMENTAL HEMATOLOGY, 2005, 33 (08) :928-934
[10]   Comparison of different culture conditions for human mesenchymal stromal cells for clinical stem cell therapy [J].
Haack-Sorensen, M. ;
Friis, T. ;
Bindslev, L. ;
Mortensen, S. ;
Johnsen, H. E. ;
Kastrup, J. .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2008, 68 (03) :192-203